Louisville, KY, July 24, 2017 -- Appriss Health, provider of the most comprehensive platform for substance use disorder in the U.S., today announced it has signed an agreement with Deaconess Health System, consisting of six hospitals in southwest Indiana, to enable integration of prescription drug monitoring program (PDMP) information directly into electronic health records (EHRs) via Appriss Health’s PMP Gateway managed service solution. PMP Gateway enables access to data, analytics, tools and resources from PDMPs within care team workflows in real-time, at the point-of-care, at every patient encounter, to improve patient safety and outcomes. The integration is the first of its kind in Indiana.
|
|||
Today, Indiana Lieutenant Governor Suzanne Crouch and Evansville Mayor Lloyd Winnecke were joined by leaders from the Indiana health community and Appriss Health at Deaconess Gateway Hospital to announce the PDMP integration into workflow. Clinicians will now be able to access a patient's prescription history within the EHR, whereas physicians and pharmacists previously needed to log into a separate INSPECT website to retrieve a patient's controlled substance dispensations from the state database and then cross-reference that data with a patient's health information in what was a time-consuming process.
“In the most recent statistics from the Indiana State Department of Health, we, unfortunately, saw opioid related deaths increase by 3.5 percent per year from 2011-2015. In addition, we saw a 60 percent increase in non-fatal ER visits from opioid overdose at the same time,” said Lieutenant Governor Suzanne Crouch. “This resource, putting INSPECT data directly in the hands of doctors making critical prescribing decisions, will save lives and support the State of Indiana in the fight against prescription drug and opioid abuse.”
“At Deaconess, we are committed to the prevention of prescription drug misuse and abuse in our patient population,” said Dr. Gina Huhnke, Director Medical Affairs and Emergency Medicine at Deaconess. “Integrating INSPECT information into daily workflow ensures prescribers at Deaconess will more often, and more easily, access this valuable prescription monitoring data to make better informed clinical decisions to better ensure patient safety. We look forward to working with the State of Indiana and Appriss Health on these important efforts.”
“Deaconess has taken a major step towards ensuring the best standard of care for its patients,” said Rob Cohen, President, Appriss Health. “We applaud them for taking a proactive approach to becoming the first health system in Indiana to deploy clinical workflow integration of PDMP data and clinical decision support solutions for substance use disorder directly within their EHR.”
PMP Gateway is a managed service platform that provides comprehensive connectivity, and access to clinical decision support, patient support, patient engagement and care coordination that interoperates seamlessly with leading EHR and pharmacy management systems, PMP InterConnect and 42 PDMPs across the U.S.
Deaconess Health System is also piloting Appriss Health’s NarxCare platform, which empowers prescribers and dispensers to identify patients that may be at risk for prescription drug addiction, overdose and death, and equips clinicians and care teams with the advanced analytics, tools and technology they need to help those patients.
About Appriss Health
Appriss Health provides the nation's most comprehensive platform for early identification, prevention and management of substance use disorder (SUD). We provide state government agencies with the most advanced repository of controlled substance dispensing data, and deliver real-time clinical decisioning support, critical insights and interventions to physicians, pharmacists, and care team members through millions of patient encounters each year. Our solutions enable healthcare providers, pharmacists, and care team members to assess and manage clinical risk in order to positively impact patient safety and population health outcomes. For more information, please visit www.apprisshealth.com.
###
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/93c1865f-801b-4836-9bfd-8a211109f3b0
David Griffin Appriss Health 502-815-3880 [email protected]


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Instagram Outage Disrupts Thousands of U.S. Users
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



